SILVER SPRING, Md. — Philip Morris International Inc. (PMI) made its case to continue to market its heat-not-burn IQOS as a ...
2don MSN
Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product
The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to ...
United States Food and Drug AdministrationRockville, MD 20852 Re: Docket No. FDA-2025-N-2030 Dear Dr. Koplow and members of the Tobacco Products Scientific Advisory Committee, The R Street Institute ...
Philip Morris International recently presented evidence to the FDA's Tobacco Products Scientific Advisory Committee to ...
International presented evidence to the Tobacco Products Scientific Advisory Committee. The committee, comprised ...
Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...
Asianet Newsable on MSN
Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions Of Device
The modified risk tobacco product designation granted by the FDA initially in 2020 allowed the company to advertise IQOS’ ...
Philip Morris International's U.S. business, PMI U.S., is investing $37 million in its manufacturing facility in Wilson, ...
Philip Morris International Inc. (PM) announced that it recently presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), a panel of independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback